article thumbnail

National cancer group reports widespread chemo shortages, calls on government and industry to help resolve them

Fierce Pharma

As pharma supply chain problems drag on, a shortage of key cancer drugs has afflicted a large number of treatment centers and many patients. | The National Comprehensive Cancer Network's recent survey shows that nearly all of the treatment centers it polled are facing a carboplatin shortage.

article thumbnail

How payers can use healthcare data to enhance network adequacy

Clarify Health

Designing and maintaining a healthcare network is no simple task—especially when it comes to meeting the needs for accessibility, quality, and cost across a diverse pool of members. Health plans need to design networks that offer members reasonable access to in-network providers to ensure the network is adequate to meet their health needs.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Streamlining Center of Excellence Provider Network Development in Record Time

Clarify Health

Healthcare Centers of Excellence are recognized for their commitment to quality, expertise, and the pursuit of the best possible outcomes for patients. They often play a critical role in advancing medical knowledge and improving patient care in specialized areas of healthcare. Feeling inspired?

article thumbnail

Revolutionizing Rare Disease Research: Unleashing the Power of Patient Advocacy and Artificial Intelligence

PM360

Exploring the role of patient advocacy groups and clinical trials while discussing the challenges faced, and how artificial intelligence and modern methods revolutionize the landscape. As a result, newly diagnosed families frequently rely on patient advocacy groups (PAGs) for up-to-date information.

article thumbnail

Webinar recap: How Cigna is Innovating their Network Design Process

Clarify Health

On December 16th, we hosted an AHIP webinar discussion about how Cigna is innovating their network design process for market expansion. Austin has spent the last eight years at Cigna with responsibility for medical economics and analytics, leading the transformation of data and analytics for their government business segment.

article thumbnail

Steps to building a more patient-centric industry

pharmaphorum

Lack of access, strict regulations, and demanding schedules have made it extremely difficult for patients to participate in clinical trials. A 2018 NIH survey found that patients felt clinical trial participation to be inconvenient and burdensome, and nearly half (49.0%) said it disrupted their daily routine.

Patients 103
article thumbnail

Championing UK ATMP clinical trials

European Pharmaceutical Review

Specifically, an additional four years of funding for the Advanced Therapy Treatment Centre (ATTC) Network is available through the programme. The funding will start with three established Centres, and then across an expanded network, according to Chief Clinical Officer for Cell and Gene Therapy Catapult, Jacqueline Barry.